The invention provides contrast agents for optical imaging of colorectal cancer (CRC) in patients. The contrast agents may be used in diagnosis of CRC, for follow up of progress in disease development, and for follow up of treatment of CRC. Further, the i
-
Example 6
(2008/06/13)
More Articles about upstream products of 848830-23-9